Skip to Main Content

Author Details

William C Jackson
University of Michigan ann arbor
2013
82
24
PMIDPaper TitleJournal TitlePublished Year
35878714A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer.Int J Radiat Oncol Biol Phys2023
37482090Local Control in Patients with Metastatic Renal Cell Carcinoma to the Spine: The Experience of an Institution with a Multidisciplinary Spine Oncology Program.World Neurosurg2023
37776158Patients with progression of spinal metastases who present to the clinic have better outcomes compared to those who present to the emergency department.Cancer Med2023
37295727Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular Carcinoma.Pract Radiat Oncol2023
34285350Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative.Prostate Cancer Prostatic Dis2022
35737923Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601.J Clin Oncol2022
35373440Development and validation of a life expectancy calculator for US patients with prostate cancer.BJU Int2022
35813938Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment.Clin Transl Radiat Oncol2022
32853708Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease.Int J Radiat Oncol Biol Phys2021
33878421The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy.Int J Radiat Oncol Biol Phys2021
33513569Survival, fusion, and hardware failure after surgery for spinal metastatic disease.J Neurosurg Spine2021
33662287Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.Lancet Oncol2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34086486End Point Definitions and Surrogacy in Prostate Cancer: Will Metastasis-Free Survival Become Event-Free Survival With Advances in Molecular Imaging?J Clin Oncol2021
34028551Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer.JAMA Netw Open2021
33275486Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.J Clin Oncol2021
31541240Local Control and Toxicity of Multilevel Spine Stereotactic Body Radiotherapy.Neurosurgery2020
35050780Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate.JCO Precis Oncol2020
31977385Surrogate Endpoints in Localized Prostate Cancer.Cancer J2020
33145460Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19.Adv Radiat Oncol2020
33090219Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.JAMA Oncol2020
33119036Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic.JAMA Oncol2020
32663537Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.Radiother Oncol2020
32997578Reply to L. C. Mendez et al and M. A. Kollmeier et al.J Clin Oncol2020
32599760Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.J Clin Med2020
32215583Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.JAMA Oncol2020
32147009Evolving Role of Stereotactic Body Radiation Therapy in the Management of Spine Metastases: Defining Dose and Dose Constraints.Neurosurg Clin N Am2020
32231245Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.Prostate Cancer Prostatic Dis2020
32292839Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19.Adv Radiat Oncol2020
32396488Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials.J Clin Oncol2020
32253019Response to Kibe Y et al. "Methodological concerns for investigating the effects of midtreatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)".Radiother Oncol2020
29778321Submandibular gland sparing when irradiating neck level IB in the treatment of oral squamous cell carcinoma.Med Dosim2019
30153435International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.J Urol2019
31584886Tissue-based genomics: which test and when.Curr Opin Urol2019
31431377A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy.Radiother Oncol2019
31276777Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.Int J Radiat Oncol Biol Phys2019
30923943Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.J Cancer Res Clin Oncol2019
30775826Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.Head Neck2019
30707231Individual and Population Comparisons of Surgery and Radiotherapy Outcomes in Prostate Cancer Using Bayesian Multistate Models.JAMA Netw Open2019
31120534Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.JAMA Oncol2019
31060795The current state of randomized clinical trial evidence for prostate brachytherapy.Urol Oncol2019
30724780Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization.Am J Clin Oncol2019
30959121Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.Int J Radiat Oncol Biol Phys2019
31162061In Reply to Slovak et al.Int J Radiat Oncol Biol Phys2019
28710895Erectile function after stereotactic body radiotherapy for localized prostate cancer.BJU Int2018
30108006Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.Int J Radiat Oncol Biol Phys2018
31100248Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.Eur Urol Oncol2018
29474748Changes in prostate orientation due to removal of a Foley catheter.Med Phys2018
29388034Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.J Neurooncol2018
29387987Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.Med Oncol2018
  • 1 - 50 of 82

Recommended Authors

Ryan Phillips
Johns Hopkins University
Career Start Year 2017
Number of shared co-authors 23
Luca F Valle
University of California los angeles
Career Start Year 2016
Number of shared co-authors 47
Jesus E Juarez
University of California Los Angeles
Career Start Year 2015
Number of shared co-authors 54
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 3
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 7
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 32
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 30
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 23
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 5
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 15
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 25
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 42
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 13
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 4
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 46
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 37
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 14
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 42
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 44
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 10
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 22
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 38
Almudena Zapatero
University Hospital La Princesa
Career Start Year 1995
Number of shared co-authors 42
Laurence Collette
Belgium International Drug Development Institute
Career Start Year 1995
Number of shared co-authors 18
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 10
Jay P Ciezki
Cleveland Clinic
Career Start Year 1995
Number of shared co-authors 45
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 43
Richard Choo
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 36
Anthony V D'Amico
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 52

Collaborators

Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 45
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 44
Robert T Dess
University of Michigan ann arbor
Co-authored papers 35
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 23
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 22
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 15
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 12
Amar U Kishan
University of California los angeles
Co-authored papers 12
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 11
Holly E Hartman
Case Western Reserve University
Co-authored papers 10
Simpa S Salami
University of Michigan Medical School ann arbor
Co-authored papers 9
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 8
Neil B Desai
University of Texas Southwestern Medical Center
Co-authored papers 7
Thomas M Pisansky
Mayo Clinic
Co-authored papers 7
Simeng Suy
MedStar Georgetown University Hospital
Co-authored papers 5
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 5
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 5
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 4
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 4
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 4
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 4
Mack Roach
University of California San Francisco
Co-authored papers 4
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 4
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 4
William Robert Lee
Duke University School of Medicine
Co-authored papers 3
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 3
Randy Vince
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 3
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 3
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 3
Michael L Steinberg
University of California los angeles
Co-authored papers 3
Release 1.2